Juvenile myelomonocytic leukemia: Report of seven cases and review of literature

Pediatric and Developmental Pathology

Volumn 12, Issue 2, 2009, Pages 136-142

  Urs, Latha ^a   Qualman, Stephen J ^a   Kahwash, Samir B ^a  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

Children; Juvenile myelomonocytic leukemia

Indexed keywords

ANEMIA; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DIAGNOSTIC ERROR; DIARRHEA; ECCHYMOSIS; FAILURE TO THRIVE; FEMALE; FEVER; HUMAN; HUMAN TISSUE; INFANT; JUVENILE MYELOMONOCYTIC LEUKEMIA; LEUKOCYTOSIS; MALE; PETECHIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RASH; SPLENOMEGALY; STREPTOCOCCAL PHARYNGITIS; SYMPTOM; THROMBOCYTOPENIA;

BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CHILD, PRESCHOOL; FATAL OUTCOME; FEMALE; HUMANS; INFANT; LEUKEMIA, MYELOMONOCYTIC, JUVENILE; MALE; MONOCYTES; SPLENOMEGALY;

EID: 63449115774     PISSN: 10935266     EISSN: 16155742     Source Type: Journal    
DOI: 10.2350/08-04-0456.1     Document Type: Article

References (25)

1. Arico M, Biondi A, Pui C-H. Juvenile myelomonocytic leukemia. Blood 1997;90:479-488.
2. Luna-Fineman S, Shannon KM, Atwater SK, et al. Myelodysplastic and myeloproliferative disorders of childhood: a study of 167 patients. Blood 1999;93:459-466.
3. Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumors: Tumors of Hematopoietic and Lymphoid Tissues. Lyon, France: IARC Press, 2001;47-48, 55-57.
4. Hasle H. Myelodysplastic and myeloproliferative disorders in children. Curr Opin Pediatr 2007;19:1-8.
5. Niemeyer CM, Arico M, Basso G, et al. Chronic Myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. Blood 1997;89:3534-3543.
6. McKenna RW. Myelodysplasia and myeloproliferative disorders in children. Am J Clin Pathol 2004;122:S58-S69.
7. Locatelli F, Nollke P, Zecca M, et al. Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial. Blood 2005;105:410-419.
8. Passmore SJ, Chessells JM, Kempski H, Hann IM, Brownbill PA, Stiller CA. Br J Hematol 2003;121:758-767.
9. Hasle H, Niemeyer CM, Chessells JM, et al. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases. Leukemia 2003;17:277-282.
10. Niemeyer CM, Fenu S, Hasle H, Mann G, Stary J, van Wering E. Differentiating juvenile myelomonocytic leukemia from infectious disease. Blood 1998;91:365-367.
11. Gassas A, Doyle JJ, Weitzman S, et al. A basic classification and a comprehensive examination of pediatric myeloproliferative syndromes. J Pediatr Hematol Oncol 2005;27:192-196.
12. Flotho C, Kratz CP, Niemeyer CM. How a rare pediatric neoplasia can give important insights into biological concepts: a perspective on juvenile myelomonocytic leukemia. Haematologica 2007;92:1441-1446.
13. Kratz CP, Niemeyer CM. Juvenile myelomonocytic leukemia. Hematology 2005;10(suppl 1):100-103.
14. Flotho C, Valcamonica S, Mach-Pascual S, et al. RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML). Leukemia 1999;13:32-37.
15. Manabe A, Yoshimasu T, Ebihara Y, et al. Viral infections in juvenile myelomonocytic leukemia: prevalence and clinical implications. J Pediatr Hematol Oncol 2004;26:636-641.
16. Janik-Moszant A, Barc-Czarnecka M, van der Berg M, et al. Concomitant EBV-related B-cell proliferation and juvenile myelomonocytic leukemia in a 2-year-old child. Leukemia Res 2008;32: 181-184.
17. Shin HT, Harris MB, Orlow SJ. Juvenile myelomonocytic leukemia presenting with features of hemophagocytic lymphohistiocytosis in association with neurofibromatosis and juvenile xanthogranulomas. J Pediatr Hematol Oncol 2004;26:591-595.
18. Gerristen A, Lam K, Schneider EM, van den Heuvel-Eibrink MM. An exclusive case of juvenile myelomonocytic leukemia in association with Kikuchi's disease and hemophagocytic lymphohistiocytosis and a review of the literature. Leukemia Res 2006;30:1299-1303.
19. Matsuda K, Shimada A, Yoshida N, et al. Spontaneous improvement of hematologic abnormalities in patients having juvenile myelomono-cytic leukemia with specific RAS mutations. Blood 2007;109:5477-5480.
20. Manabe A, Okamura J, Yumura-yagi K, et al. Allogeneic hematopoi-etic stem cell transplantation for 27 children with juvenile myelomonocytic leukemia diagnosed based on the criteria of the International JMML Working Group. Leukemia 2002;16:645-649.
21. Korthof ET, Snijder PP, de GraaffAA, et al. Allogeneic bone marrow transplantation for juvenile myelomonocytic leukemia: a single center experience of 23 patients. Bone Marrow Transplant 2005;35:455-461.
22. Woods WG, Barnard DR, Alonzo TA, et al. Prospective study of 90 children requiring treatment for juvenile myelomonocytic leukemia or myelodysplastic syndrome: a report from the Children's Cancer Group. J Clin Oncol 2002;20:434-440.
23. Yoshimi A, Niemeyer CM, Bohmer V, et al. Chimaerism analyses and subsequent immunological intervention after stem cell transplantation in patients with juvenile myelomonocytic leukemia. Br J Hematol 2005;129:542-549.
24. Bader P, Niemeyer CM, Weber G, et al. WT1 gene expression: useful marker for minimal residual disease in childhood myelodysplastic syndromes and juvenile myelo-monocytic leukemia? Eur J Hematol 2004;73:25-28.
25. Archambeault S, Flores NJ, Yoshimi A, et al. Development of an allele-specific minimal residual disease assay for patients with juvenile myelomonocytic leukemia. Blood 2008;11:1124-1127.